FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896989108> ?p ?o ?g. }

• W2896989108 abstract "Background: The development of stroke while on continuous flow left ventricular assist device (CF-LVAD) remains a source of significant morbidity and mortality. The ability to risk stratify these patients can improve postoperative management. Objective: To describe the overall experience of cerebrovascular accidents in CF-LVAD patients at a large volume tertiary center and compare the utility of CHADS 2 , CHA 2 DS 2 -VASc, and R 2 CHADS 2 scores. Methods: A retrospective analysis of 522 patients (524 CF-LVADs: HeartMate-II=402; Heartware=122), between 2003 and 2016, was conducted. Post-operative heparin for 2-3 days, warfarin (goal INR 2-3), and 80-325mg aspirin were administered daily. Cerebrovascular vascular accident (CVA) was defined as any focal or global deficit with positive imaging. The CHADS 2 , R 2 CHADS 2 and CHA 2 DS 2 -VASc scores were calculated. Baseline characteristics and risk assessment scores were compared between patients with ischemic CVA (ICVA) and no CVA (nCVA). Kaplan-Meier analysis was conducted. Results: Mean age was 54.7±13.6 years, 21.8% were female and 44.8% had ischemic cardiomyopathy. Eighty patients (15.3%) had 98 events of ICVA. Median duration between implant and ICVA was 127 [range 1-2226] days. Hemorrhagic conversion occurred in 9 (9.2%) patients. The CHADS 2 (ICVA=2.4±1.0, nCVA=2.3±1.1, p-value=0.53), CHA 2 DS 2 -VASc (ICVA=3.2±1.3, nCVA=2.9±1.3, p-value=0.08) and R 2 CHADS 2 (ICVA=3.5±1.5, nCVA=3.2±1.6, p-value=0.22) were all higher for ICVA cohort. Patients with multiple ICVAs had a mean CHADS 2 score of 2.5±0.74, CHA 2 DS 2 -VASc score of 3.5±1.1, and R 2 CHADS 2 score of 4±1.2. Freedom from stroke was significantly lower in the CHA 2 DS 2 -VASc ≥3 compared to the CHA 2 DS 2 -VASc <3 [Figure: Kaplan-Meier log-rank p-value=0.009]. Conclusion: CHA 2 DS 2 -VASc of ≥3 was associated with ICVA in this cohort of CF-LVAD patients. Specifically tailored risk-scores are needed to better predict those at risk for neurological events in CF-LVADs" @default.
• W2896989108 created "2018-10-26" @default.
• W2896989108 creator A5014413454 @default.
• W2896989108 creator A5017994911 @default.
• W2896989108 creator A5032887574 @default.
• W2896989108 creator A5033027008 @default.
• W2896989108 creator A5037153489 @default.
• W2896989108 creator A5042802176 @default.
• W2896989108 creator A5056062246 @default.
• W2896989108 creator A5056199654 @default.
• W2896989108 creator A5062554000 @default.
• W2896989108 creator A5076621218 @default.
• W2896989108 creator A5077168133 @default.
• W2896989108 creator A5082566599 @default.
• W2896989108 creator A5087980707 @default.
• W2896989108 creator A5090346613 @default.
• W2896989108 date "2018-01-22" @default.
• W2896989108 modified "2023-09-27" @default.
• W2896989108 title "Abstract TP392: Evaluation of the CHADS 2 , CHA 2 DS 2 -VASc, and R 2 CHADS 2 Risk Assessment Scores in Continuous Flow LVADs" @default.
• W2896989108 doi "https://doi.org/10.1161/str.49.suppl_1.tp392" @default.
• W2896989108 hasPublicationYear "2018" @default.
• W2896989108 type Work @default.
• W2896989108 sameAs 2896989108 @default.
• W2896989108 citedByCount "0" @default.
• W2896989108 crossrefType "journal-article" @default.
• W2896989108 hasAuthorship W2896989108A5014413454 @default.
• W2896989108 hasAuthorship W2896989108A5017994911 @default.
• W2896989108 hasAuthorship W2896989108A5032887574 @default.
• W2896989108 hasAuthorship W2896989108A5033027008 @default.
• W2896989108 hasAuthorship W2896989108A5037153489 @default.
• W2896989108 hasAuthorship W2896989108A5042802176 @default.
• W2896989108 hasAuthorship W2896989108A5056062246 @default.
• W2896989108 hasAuthorship W2896989108A5056199654 @default.
• W2896989108 hasAuthorship W2896989108A5062554000 @default.
• W2896989108 hasAuthorship W2896989108A5076621218 @default.
• W2896989108 hasAuthorship W2896989108A5077168133 @default.
• W2896989108 hasAuthorship W2896989108A5082566599 @default.
• W2896989108 hasAuthorship W2896989108A5087980707 @default.
• W2896989108 hasAuthorship W2896989108A5090346613 @default.
• W2896989108 hasConcept C126322002 @default.
• W2896989108 hasConcept C127413603 @default.
• W2896989108 hasConcept C141071460 @default.
• W2896989108 hasConcept C164705383 @default.
• W2896989108 hasConcept C2776301958 @default.
• W2896989108 hasConcept C2779161974 @default.
• W2896989108 hasConcept C2780645631 @default.
• W2896989108 hasConcept C71924100 @default.
• W2896989108 hasConcept C78519656 @default.
• W2896989108 hasConceptScore W2896989108C126322002 @default.
• W2896989108 hasConceptScore W2896989108C127413603 @default.
• W2896989108 hasConceptScore W2896989108C141071460 @default.
• W2896989108 hasConceptScore W2896989108C164705383 @default.
• W2896989108 hasConceptScore W2896989108C2776301958 @default.
• W2896989108 hasConceptScore W2896989108C2779161974 @default.
• W2896989108 hasConceptScore W2896989108C2780645631 @default.
• W2896989108 hasConceptScore W2896989108C71924100 @default.
• W2896989108 hasConceptScore W2896989108C78519656 @default.
• W2896989108 hasIssue "Suppl_1" @default.
• W2896989108 hasLocation W28969891081 @default.
• W2896989108 hasOpenAccess W2896989108 @default.
• W2896989108 hasPrimaryLocation W28969891081 @default.
• W2896989108 hasRelatedWork W2039531178 @default.
• W2896989108 hasRelatedWork W2064430680 @default.
• W2896989108 hasRelatedWork W2076292091 @default.
• W2896989108 hasRelatedWork W2114223015 @default.
• W2896989108 hasRelatedWork W2140623030 @default.
• W2896989108 hasRelatedWork W2157689025 @default.
• W2896989108 hasRelatedWork W2172069617 @default.
• W2896989108 hasRelatedWork W2274835053 @default.
• W2896989108 hasRelatedWork W2415605004 @default.
• W2896989108 hasRelatedWork W3193900294 @default.
• W2896989108 hasVolume "49" @default.
• W2896989108 isParatext "false" @default.
• W2896989108 isRetracted "false" @default.
• W2896989108 magId "2896989108" @default.
• W2896989108 workType "article" @default.